Cyberonics Reaches New 52-Week High (CYBX)

NEW YORK ( TheStreet) -- Cyberonics (Nasdaq: CYBX) hit a new 52-week high Monday as it is currently trading at $39.28, above its previous 52-week high of $39.18 with 16,731 shares traded as of 9:53 a.m. ET. Average volume has been 196,400 shares over the past 30 days.

Cyberonics has a market cap of $901.5 million and is part of the health care sector and health services industry. Shares are up 16.1% year to date as of the close of trading on Friday.

Cyberonics, Inc., a neuromodulation company, engages in the design, development, sale, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of refractory epilepsy and treatment-resistant depression. The company has a P/E ratio of 33.6, above the average health services industry P/E ratio of 30.5 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Cyberonics as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Cyberonics Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing